Human papillomavirus type 77 E7 protein is a weak deregulator of cell cycle

Cancer Letters

Volumn 246, Issue 1-2, 2007, Pages 274-281

  Mansour, Mariam ^a   Touka, Majid ^a   Malena, Adriana ^b   Indiveri, Cesare ^b   Dong, Wen ^a   Gionfriddo, Ilaria ^a   Accardi, Rosita ^a   Paradiso, Angelo ^c   Sylla, Bakary S ^a   Gabet, Anne Sophie ^a   Tommasino, Massimo ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF CALABRIA   (Italy)

^c NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Cell cycle; Cutaneous human papillomavirus type 77; E7 oncoprotein; Non melanoma skin cancer

Indexed keywords

BETA TUBULIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; ONCOPROTEIN; PROTEIN E7; PROTEIN P16INK4A; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CYCLE REGULATION; CELL PROLIFERATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 77; IMMUNE DEFICIENCY; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CANCER; WART VIRUS;

ANIMALS; CELL CYCLE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE EXPRESSION; GENETIC VECTORS; HUMANS; IMMUNOBLOTTING; MICE; NIH 3T3 CELLS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PROTEIN BINDING; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 77;

EID: 33845640062     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.03.006     Document Type: Article

References (29)

1. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., and zur Hausen H. Classification of papillomaviruses. Virology 324 (2004) 17-27
2. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2 (2002) 342-350
3. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., Snijders P.J., and Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 (2003) 518-527
4. M. Tommasino, Early genes of human papillomaviruses, in: Encyclopedic Reference of Cancer, Springer, Heidelberg, Germany, 2001, pp. 266-272.
5. Hartevelt M.M., Bavinck J.N., Kootte A.M., Vermeer B.J., and Vandenbroucke J.P. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 49 (1990) 506-509
6. Jablonska S., Dabrowski J., and Jakubowicz K. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res. 32 (1972) 583-589
7. Majewski S., Jablonska S., and Orth G. Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression. Clin. Dermatol. 15 3 (1997) 321-334
8. Orth G., Jablonska S., Jarzabek-Chorzelska M., Obalek S., Rzesa G., Favre M., et al. Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res. 39 (1979) 1074-1082
9. Pfister H. Chapter 8: human papillomavirus and skin cancer. J. Natl Cancer Inst. Monogr. 31 (2003) 52-56
10. Jackson S., Harwood C., Thomas M., Banks L., and Storey A. Role of bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev. 14 (2000) 3065-3073
11. Caldeira S., Zehbe I., Accardi R., Malanchi I., Dong W., Giarre M., et al. The E6 and E7 proteins of cutaneous human papillomavirus type 38 display transforming properties,. J. Virol. 77 (2003) 2195-2206
12. W. Dong, U. Klotz, R. Accardi, S. Caldeira, W.M. Tong, Z.Q. Wang, et al., Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type, J. Virol. 79 (2005) 14899-14908.
13. Schaper I.D., Marcuzzi G.P., Weissenborn S.J., Kasper H.U., Dries V., Smyth N., et al. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res. 65 (2005) 1394-1400
14. Purdie K.J., Pennington J., Proby C.M., Khalaf S., de Villiers E.M., Leigh I.M., et al. The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence. Eur. Mol. Biol. Org. J. 18 (1999) 5359-5369
15. Giampieri S., Garcia-Escudero R., Green J., and Storey A. Human papillomavirus type 77 E6 protein selectively inhibits p53-dependent transcription of proapoptotic genes following UV-B irradiation. Oncogene 23 (2004) 5864-5870
16. Morgenstern J.P., and Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18 (1990) 3587-3596
17. Pear W.S., Nolan G.P., Scott M.L., and Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl Acad. Sci. USA 90 (1993) 8392-8396
18. Serrano M., Lin A.W., McCurrach M.E., Beach D., and Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 (1997) 593-602
19. Giarre M., Caldeira S., Malanchi I., Ciccolini F., Leao M.J., and Tommasino M. Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle Arrest. J. Virol. 75 (2001) 4705-4712
20. Vlach J., Hennecke S., Alevizopoulos K., Conti D., and Amati B. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. Eur. Mol. Biol. Org. J. 15 (1996) 6595-6604
21. Caldeira S., de Villiers E.M., and Tommasino M. Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein. Oncogene 19 (2000) 821-826
22. Boyer S.N., Wazer D.E., and Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 56 (1996) 4620-4624
23. Jones D.L., and Munger K. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J. Virol. 71 (1997) 2905-2912
24. Alunni-Fabbroni M., Littlewood T., Deleu L., Caldeira S., Giarre M., Dell' Orco, M., et al. Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts. Oncogene 19 (2000) 2277-2285
25. Gonzalez S.L., Stremlau M., He X., Basile J.R., and Munger K. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J. Virol. 75 (2001) 7583-7591
26. Caldeira S., Dong W., Tomakidi P., Paradiso A., and Tommasino M. Human papillomavirus type 32 does not display in vitro transforming properties. Virology 301 (2002) 157-164
27. Ciccolini F., Di Pasquale G., Carlotti F., Crawford L., and Tommasino M. Functional Studies of E7 proteins from different HPV types. Oncogene 9 (1994) 2342-2348
28. Schmitt A., Harry J.B., Rapp B., Wettstein F.O., and Iftner T. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1. J. Virol. 68 (1994) 7051-7059
29. Malanchi I., Accardi R., Diehl F., Smet A., Androphy E., Hoheisel J., and Tommasino M. Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression. J. Virol. 78 (2004) 13769-13778